Monday 23rd
August, when the first blatant step was taken to mandate COVID-19 vaccine in
Nigeria happened to be the same day that the US Food and Drugs Agency announced
the approval of the first vaccine ever for COVID-19. And Nigeria’s NAFDAC has made it clear that
all it will do is simply apply a dubious protocol called “Reliance” to repeat
the same pronouncement made by a more “matured regulatory Agency” such as the
US FDA. Makes you wonder why we need the
NAFDAC at all then!
Anyway, the US FDA vaccine is produced by Pfizer and
has as brand name Comirnaty. For some,
this has taken care of the legal requirement that only an approved medical
product can be at all mandated.
Not so fast!
On the one hand, the approval for Comirnaty does not
apply to other vaccines, not even the Pfizer-Biotech vaccine produced by the
same company, which is currently being administered in its millions under
Emergency Use Authorization. Recall that in its Vaccine Passport scheme, the
European Medicine Agency’s insisted that its approval for the Oxford Astra Zeneca
vaccine produced under the brand name Vaxzevria
in the UK and Asia was not applicable to the Covishield brand produced in
India, and supplied to Africa!
On the other hand, Nigeria does not even have the
Pfizer-Biotech EUA experimental vaccine, not to talk of the Comirnaty, which is
being produced in very limited quantity, with the expectation that beguiled
people will not notice the difference between it and the Pfizer-Biotech
product. The big issue is that the
non-liability coverage of the latter does not apply to Comirnaty. If people gullibly took Pfizer-Biotech
vaccine (under a mandate that is applicable only to Comirnaty) and developed
adverse response, nobody would be liable.
However if it is Comirnaty that they actually received as mandated,
there would be room for numerous legal tussles which could prove damaging for
the company Pfizer. Hence Comirnaty has
been produced in very limited quantity, insufficient even for the US market
alone.
Check the details of all these legal and commercial
intrigues in the fine article at https://childrenshealthdefense.org/defender/mainstream-media-fda-approval-pfizer-vaccine/
See you next week, God willing.